RT Book, Section A1 Leavitt, Andrew D. A1 Price, Erika Leemann A2 Papadakis, Maxine A. A2 McPhee, Stephen J. A2 Rabow, Michael W. A2 McQuaid, Kenneth R. SR Print(0) ID 1193159051 T1 Antithrombotic Therapy T2 Current Medical Diagnosis & Treatment 2023 YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781264687343 LK accessmedicine.mhmedical.com/content.aspx?aid=1193159051 RD 2024/03/29 AB Key Clinical Updates in Antithrombotic TherapyFor patients with morbid obesity, standard doses of apixaban or rivaroxaban should be chosen rather than dabigatran or edoxaban.DOACs are not recommended for VTE treatment in the acute setting following bariatric surgery but can be considered for ongoing treatment after the initial 4 weeks of therapy.Heparins may be preferable as initial therapy in hospitalized patients with clinical instability and fluctuating renal or hepatic function, when bleeding risk is high, or when there is concern that thrombolysis may be required.Stevens SM et al. Chest. [PMID: 34352278]